Management of stroke in infants and children: A scientific statement from a special writing group of the american heart association stroke council and the council on cardiovascular disease in the young

E. Steve Roach, Meredith Golomb, Robert Adams, Jose Biller, Stephen Daniels, Gabrielle Deveber, Donna Ferriero, Blaise V. Jones, Fenella J. Kirkham, R. Michael Scott, Edward R. Smith

Research output: Contribution to journalArticle

664 Citations (Scopus)

Abstract

PURPOSE: The purpose of this statement is to review the literature on childhood stroke and to provide recommendations for optimal diagnosis and treatment. This statement is intended for physicians who are responsible for diagnosing and treating infants, children, and adolescents with cerebrovascular disease. METHODS: The Writing Group members were appointed by the American Heart Association Stroke Councilĝ€™s Scientific Statement Oversight Committee. The panel included members with several different areas of expertise. Each of the panelĝ€™s recommendations was weighted by applying the American Heart Association Stroke Councilĝ€™s Levels of Evidence grading algorithm. After being reviewed by panel members, the manuscript was reviewed by 4 expert peer reviewers and by members of the Stroke Council Leadership Committee and was approved by the American Heart Association Science Advisory and Coordinating Committee. We anticipate that this statement will need to be updated in 4 years. RESULTS: Evidence-based recommendations are provided for the prevention of ischemic stroke caused by sickle cell disease, moyamoya disease, cervicocephalic arterial dissection, and cardiogenic embolism. Recommendations on the evaluation and management of hemorrhagic stroke also are provided. Protocols for dosing of heparin and warfarin in children are suggested. Also included are recommendations on the evaluation and management of perinatal stroke and cerebral sinovenous thrombosis in children.

Original languageEnglish
Pages (from-to)2644-2691
Number of pages48
JournalStroke
Volume39
Issue number9
DOIs
StatePublished - Sep 1 2008
Externally publishedYes

Fingerprint

American Heart Association
Cardiovascular Diseases
Stroke
Moyamoya Disease
Cerebrovascular Disorders
Intracranial Thrombosis
Manuscripts
Sickle Cell Anemia
Advisory Committees
Warfarin
Embolism
Heparin
Dissection
Physicians

Keywords

  • AHA Scientific Statements
  • Children
  • Stroke

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Clinical Neurology
  • Advanced and Specialized Nursing
  • Medicine(all)

Cite this

Management of stroke in infants and children : A scientific statement from a special writing group of the american heart association stroke council and the council on cardiovascular disease in the young. / Roach, E. Steve; Golomb, Meredith; Adams, Robert; Biller, Jose; Daniels, Stephen; Deveber, Gabrielle; Ferriero, Donna; Jones, Blaise V.; Kirkham, Fenella J.; Scott, R. Michael; Smith, Edward R.

In: Stroke, Vol. 39, No. 9, 01.09.2008, p. 2644-2691.

Research output: Contribution to journalArticle

Roach, E. Steve ; Golomb, Meredith ; Adams, Robert ; Biller, Jose ; Daniels, Stephen ; Deveber, Gabrielle ; Ferriero, Donna ; Jones, Blaise V. ; Kirkham, Fenella J. ; Scott, R. Michael ; Smith, Edward R. / Management of stroke in infants and children : A scientific statement from a special writing group of the american heart association stroke council and the council on cardiovascular disease in the young. In: Stroke. 2008 ; Vol. 39, No. 9. pp. 2644-2691.
@article{12ae5210076448779fecb4b5368bb0cb,
title = "Management of stroke in infants and children: A scientific statement from a special writing group of the american heart association stroke council and the council on cardiovascular disease in the young",
abstract = "PURPOSE: The purpose of this statement is to review the literature on childhood stroke and to provide recommendations for optimal diagnosis and treatment. This statement is intended for physicians who are responsible for diagnosing and treating infants, children, and adolescents with cerebrovascular disease. METHODS: The Writing Group members were appointed by the American Heart Association Stroke Councilĝ€™s Scientific Statement Oversight Committee. The panel included members with several different areas of expertise. Each of the panelĝ€™s recommendations was weighted by applying the American Heart Association Stroke Councilĝ€™s Levels of Evidence grading algorithm. After being reviewed by panel members, the manuscript was reviewed by 4 expert peer reviewers and by members of the Stroke Council Leadership Committee and was approved by the American Heart Association Science Advisory and Coordinating Committee. We anticipate that this statement will need to be updated in 4 years. RESULTS: Evidence-based recommendations are provided for the prevention of ischemic stroke caused by sickle cell disease, moyamoya disease, cervicocephalic arterial dissection, and cardiogenic embolism. Recommendations on the evaluation and management of hemorrhagic stroke also are provided. Protocols for dosing of heparin and warfarin in children are suggested. Also included are recommendations on the evaluation and management of perinatal stroke and cerebral sinovenous thrombosis in children.",
keywords = "AHA Scientific Statements, Children, Stroke",
author = "Roach, {E. Steve} and Meredith Golomb and Robert Adams and Jose Biller and Stephen Daniels and Gabrielle Deveber and Donna Ferriero and Jones, {Blaise V.} and Kirkham, {Fenella J.} and Scott, {R. Michael} and Smith, {Edward R.}",
year = "2008",
month = "9",
day = "1",
doi = "10.1161/STROKEAHA.108.189696",
language = "English",
volume = "39",
pages = "2644--2691",
journal = "Stroke",
issn = "0039-2499",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

TY - JOUR

T1 - Management of stroke in infants and children

T2 - A scientific statement from a special writing group of the american heart association stroke council and the council on cardiovascular disease in the young

AU - Roach, E. Steve

AU - Golomb, Meredith

AU - Adams, Robert

AU - Biller, Jose

AU - Daniels, Stephen

AU - Deveber, Gabrielle

AU - Ferriero, Donna

AU - Jones, Blaise V.

AU - Kirkham, Fenella J.

AU - Scott, R. Michael

AU - Smith, Edward R.

PY - 2008/9/1

Y1 - 2008/9/1

N2 - PURPOSE: The purpose of this statement is to review the literature on childhood stroke and to provide recommendations for optimal diagnosis and treatment. This statement is intended for physicians who are responsible for diagnosing and treating infants, children, and adolescents with cerebrovascular disease. METHODS: The Writing Group members were appointed by the American Heart Association Stroke Councilĝ€™s Scientific Statement Oversight Committee. The panel included members with several different areas of expertise. Each of the panelĝ€™s recommendations was weighted by applying the American Heart Association Stroke Councilĝ€™s Levels of Evidence grading algorithm. After being reviewed by panel members, the manuscript was reviewed by 4 expert peer reviewers and by members of the Stroke Council Leadership Committee and was approved by the American Heart Association Science Advisory and Coordinating Committee. We anticipate that this statement will need to be updated in 4 years. RESULTS: Evidence-based recommendations are provided for the prevention of ischemic stroke caused by sickle cell disease, moyamoya disease, cervicocephalic arterial dissection, and cardiogenic embolism. Recommendations on the evaluation and management of hemorrhagic stroke also are provided. Protocols for dosing of heparin and warfarin in children are suggested. Also included are recommendations on the evaluation and management of perinatal stroke and cerebral sinovenous thrombosis in children.

AB - PURPOSE: The purpose of this statement is to review the literature on childhood stroke and to provide recommendations for optimal diagnosis and treatment. This statement is intended for physicians who are responsible for diagnosing and treating infants, children, and adolescents with cerebrovascular disease. METHODS: The Writing Group members were appointed by the American Heart Association Stroke Councilĝ€™s Scientific Statement Oversight Committee. The panel included members with several different areas of expertise. Each of the panelĝ€™s recommendations was weighted by applying the American Heart Association Stroke Councilĝ€™s Levels of Evidence grading algorithm. After being reviewed by panel members, the manuscript was reviewed by 4 expert peer reviewers and by members of the Stroke Council Leadership Committee and was approved by the American Heart Association Science Advisory and Coordinating Committee. We anticipate that this statement will need to be updated in 4 years. RESULTS: Evidence-based recommendations are provided for the prevention of ischemic stroke caused by sickle cell disease, moyamoya disease, cervicocephalic arterial dissection, and cardiogenic embolism. Recommendations on the evaluation and management of hemorrhagic stroke also are provided. Protocols for dosing of heparin and warfarin in children are suggested. Also included are recommendations on the evaluation and management of perinatal stroke and cerebral sinovenous thrombosis in children.

KW - AHA Scientific Statements

KW - Children

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=52449090507&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=52449090507&partnerID=8YFLogxK

U2 - 10.1161/STROKEAHA.108.189696

DO - 10.1161/STROKEAHA.108.189696

M3 - Article

C2 - 18635845

AN - SCOPUS:52449090507

VL - 39

SP - 2644

EP - 2691

JO - Stroke

JF - Stroke

SN - 0039-2499

IS - 9

ER -